COVID-19 Therapeutics I: Restoration of endothelial barrier function using adrecizumab to treat life-threatening organ failure (RESCUE) - initiation and overall coordination
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 03LW0002K
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$283,136.45Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
AdrenoMed AGResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
N/A